236 related articles for article (PubMed ID: 16546673)
1. Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects.
Lin KJ; Liu CY; Wey SP; Hsiao IT; Wu J; Fu YK; Yen TC
Nucl Med Biol; 2006 Feb; 33(2):193-202. PubMed ID: 16546673
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
Newberg AB; Plössl K; Mozley PD; Stubbs JB; Wintering N; Udeshi M; Alavi A; Kauppinen T; Kung HF
J Nucl Med; 2004 May; 45(5):834-41. PubMed ID: 15136634
[TBL] [Abstract][Full Text] [Related]
3. Brain kinetics of the new selective serotonin transporter tracer [(123)I]ADAM in healthy young adults.
Booij J; de Win MM
Nucl Med Biol; 2006 Feb; 33(2):185-91. PubMed ID: 16546672
[TBL] [Abstract][Full Text] [Related]
4. In vivo quantification by SPECT of [123I] ADAM bound to serotonin transporters in the brains of rabbits.
Ye XX; Hwang JJ; Hsieh JF; Chen JC; Chou YT; Tu KY; Wey SP; Ting G
Nucl Med Biol; 2004 Nov; 31(8):995-1003. PubMed ID: 15607481
[TBL] [Abstract][Full Text] [Related]
5. SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers.
Catafau AM; Pérez V; Penengo MM; Bullich S; Danús M; Puigdemont D; Pascual JC; Corripio I; Llop J; Perich J; Alvarez E
J Nucl Med; 2005 Aug; 46(8):1301-9. PubMed ID: 16085586
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results.
Kauppinen TA; Bergström KA; Heikman P; Hiltunen J; Ahonen AK
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):132-6. PubMed ID: 12483421
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the binding sites for 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography.
Lin KJ; Yen TC; Wey SP; Hwang JJ; Ye XX; Tzen KY; Fu YK; Chen JC
J Nucl Med; 2004 Apr; 45(4):673-81. PubMed ID: 15073265
[TBL] [Abstract][Full Text] [Related]
8. Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.
Sacher J; Asenbaum S; Klein N; Geiss-Granadia T; Mossaheb N; Poetzi C; Attarbaschi T; Lanzenberger R; Spindelegger C; Rabas A; Heinze G; Dudczak R; Kasper S; Tauscher J
Int J Neuropsychopharmacol; 2007 Apr; 10(2):211-8. PubMed ID: 16487452
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans.
Frokjaer VG; Pinborg LH; Madsen J; de Nijs R; Svarer C; Wagner A; Knudsen GM
J Nucl Med; 2008 Feb; 49(2):247-54. PubMed ID: 18199621
[TBL] [Abstract][Full Text] [Related]
10. 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand.
Oya S; Choi SR; Hou C; Mu M; Kung MP; Acton PD; Siciliano M; Kung HF
Nucl Med Biol; 2000 Apr; 27(3):249-54. PubMed ID: 10832081
[TBL] [Abstract][Full Text] [Related]
11. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.
Lemoine L; Lieberman BP; Ploessl K; Zheng P; Kung HF
Nucl Med Biol; 2013 Oct; 40(7):879-86. PubMed ID: 23856117
[TBL] [Abstract][Full Text] [Related]
12. Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.
Acton PD; Choi SR; Hou C; Plössl K; Kung HF
J Nucl Med; 2001 Oct; 42(10):1556-62. PubMed ID: 11585873
[TBL] [Abstract][Full Text] [Related]
13. Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates.
Huang WS; Ma KH; Cheng CY; Chen CY; Fu YK; Chou YH; Wey SP; Liu JC
Nucl Med Commun; 2004 May; 25(5):515-9. PubMed ID: 15100512
[TBL] [Abstract][Full Text] [Related]
14. Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study.
Erlandsson K; Sivananthan T; Lui D; Spezzi A; Townsend CE; Mu S; Lucas R; Warrington S; Ell PJ
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1329-36. PubMed ID: 16133377
[TBL] [Abstract][Full Text] [Related]
15. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
[TBL] [Abstract][Full Text] [Related]
16. Change over time in brain serotonin transporter binding in major depression: effects of therapy measured with [(123) I]-ADAM SPECT.
Amsterdam JD; Newberg AB; Newman CF; Shults J; Wintering N; Soeller I
J Neuroimaging; 2013 Oct; 23(4):469-76. PubMed ID: 23751132
[TBL] [Abstract][Full Text] [Related]
17. Imaging serotonin transporters using [123I]ADAM SPECT in a parkinsonian primate model.
Ma KH; Huang WS; Huang SY; Cheng CY; Chen CY; Shen LH; Liu JC; Fu YK
Appl Radiat Isot; 2008 Dec; 66(12):1799-803. PubMed ID: 18703341
[TBL] [Abstract][Full Text] [Related]
18. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
[TBL] [Abstract][Full Text] [Related]
19. Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain.
Choi SR; Hou C; Oya S; Mu M; Kung MP; Siciliano M; Acton PD; Kung HF
Synapse; 2000 Dec; 38(4):403-12. PubMed ID: 11044887
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution study of [(123)I] ADAM in mice: correlation with whole body autoradiography.
Lin KJ; Ye XX; Yen TC; Wey SP; Tzen KY; Ting G; Hwang JJ
Nucl Med Biol; 2002 Aug; 29(6):643-50. PubMed ID: 12234588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
